ALPHA TRIBE

Sanofi India LimitedBoard Meeting, 04-08-2026: Outcome of Board Meeting

04-08-2026 | 08:21 pm

Sanofi India's board approved its Q2 & H1 financial results. Profits before tax jumped 19% to ₹112.3 Cr, driven by 8% domestic sales growth and a 14% surge in its insulin portfolio. The company also announced a CFO change, effective September 30.

No comments yet. Be the first to comment!

All announcements from Sanofi India Limited